Hansoh Pharmaceutical Group was founded in 1995. It is a leading enterprise in the R&D and production of anti-tumor and psychotropic drugs in China, and one of the most innovative pharmaceutical companies in the country, ranking among the top 30 in China's pharmaceutical industry in terms of overall strength. Adhering to the corporate mission of "Serving Society, Creating Health," Hansoh is dedicated to innovative development across six therapeutic areas: anti-tumor, psychiatric, endocrine, gastrointestinal, cardiovascular, and anti-infective diseases. It has R&D centers in New Jersey, USA, Shanghai, China, and Lianyungang, Jiangsu, with a marketing network covering the whole country, and key products exported to over 10 countries and regions.
[Innovative R&D]: Aiming at the world's frontier, focusing on key areas, and concentrating on new drug development. Hansoh has more than 1,000 technical talents including masters and doctors, and maintains extensive exchanges and cooperation with well-known R&D institutions at home and abroad. The level of product R&D in key areas is in line with international standards, and its innovation capability ranks among the top three in the industry. It has undertaken more than 20 national major new drug innovation projects, applied for over 300 domestic and international invention patents, and applied for and approved more than 20 national Class 1.1 new drugs, among which "Mailinda," the first domestic innovative anti-anaerobic drug, has been successfully launched. The anti-tumor drug "Zefei" and the psychiatric drug "Olanning" have won the second prize of the National Science and Technology Progress Award.
[Consistent Quality]: All staff, all processes, continuous improvement. From strictly implementing standards, improving internal control standards, to proactively surpassing international and original manufacturer standards, Hansoh manufacturing strives for excellence. Two anti-tumor injections, "Zefei" and "Gainuo," have been the first to pass the FDA certification in the United States.
[Sincere Dreams]: While committed to drug R&D and innovation, Hansoh actively disseminates internationally advanced medication and diagnosis concepts, and devotes itself to public welfare undertaking focusing on education and healthcare, making health dreams come true.
[Far-reaching Future]: Hansoh will uphold the concepts of management innovation, technological innovation, and product innovation, accelerate the convergence and integration of development factors such as high-end talents, innovative technologies, and lean intelligent manufacturing, and work hand in hand with pharmaceutical peers worldwide to contribute wisdom and strength to the cause of human health.
What does Shanghai Hansoh Biomedical Technology Co., Ltd. require? Who is Shanghai Hansoh Biomedical Technology Co., Ltd. hiring? recruitment: 医疗卫生/美容保健类占比最多占78.9%，其次是生物/制药/化工/环保类占36.6%. What education can get in at ? 本科占比最多占86.2%，其次是硕士占9.8%. High education required at ? 硕士占9.8%，博士占0.8%. Work experience required at ? 不限占比最多占46.3%，其次是1-3年占35%. Where are the job locations at ? 上海占比最多占25.2%，其次是南昌占6.5%. Based on job postings from the past year, for reference only.
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
